Cargando…

Estimating health-state utility values for patients with recurrent ovarian cancer using Functional Assessment of Cancer Therapy – General mapping algorithms

OBJECTIVES: In the absence of EuroQol 5D data, mapping algorithms can be used to predict health-state utility values (HSUVs) for use in economic evaluation. In a placebo-controlled Phase II study of olaparib maintenance therapy (NCT00753545), health-related quality of life was measured using the Fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hettle, Robert, Borrill, John, Suri, Gaurav, Wulff, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664440/ https://www.ncbi.nlm.nih.gov/pubmed/26648747 http://dx.doi.org/10.2147/CEOR.S92078

Ejemplares similares

Towards a more general understanding of the algorithmic utility of recurrent connections
por: Larsen, Brett W., et al.
Publicado: (2022)

Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer” (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)’
por: Hettle, Robert, et al.
Publicado: (2023)

Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer
por: Hettle, Robert, et al.
Publicado: (2021)

Estimation of health state utilities in breast cancer
por: Kim, Seon-Ha, et al.
Publicado: (2017)

Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer
por: Zhu, Jie Wei, et al.
Publicado: (2023)

Estimating Joint Health State Utility Algorithms Under Partial Information
por: Bray, Jeremy W., et al.
Publicado: (2023)

Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2021)

Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian)
por: Evrard, Camille, et al.
Publicado: (2021)

Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea
por: Lim, Jaeok, et al.
Publicado: (2019)

Treatment algorithm in patients with ovarian cancer
por: Vergote, I, et al.
Publicado: (2020)

RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer
por: Liao, Cui, et al.
Publicado: (2022)

Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data
por: Izci, Hava, et al.
Publicado: (2023)

Estimating utility value for female genital mutilation
por: Alinia, Cyrus, et al.
Publicado: (2020)

An integrative model for recurrence in ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Palbociclib in the treatment of recurrent ovarian cancer
por: Lee, Dai Wee, et al.
Publicado: (2020)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan
por: Iwatani, Tsuguo, et al.
Publicado: (2021)

A Case Report Demonstrating Unambiguous Clinical Utility of Pet/CT Scanning in Recurrent Ovarian Cancer
por: Mutch, David, et al.
Publicado: (2009)

Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
por: Round, Jeff, et al.
Publicado: (2017)

EM algorithm for Bayesian estimation of genomic breeding values
por: Hayashi, Takeshi, et al.
Publicado: (2010)

Shared decision making in recurrent ovarian cancer: Implementation of patient decision aids across three departments of oncology in Denmark
por: Wulff, Christian Nielsen, et al.
Publicado: (2022)

Meta-analysis of the diagnostic value of (18)F-FDG PET/CT in the recurrence of epithelial ovarian cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

Algorithms to estimate the lower bounds of recombination with or without recurrent mutations
por: Liu, Xiaoming, et al.
Publicado: (2008)

Development, implementation and evaluation of patient decision aids supporting shared decision making in women with recurrent ovarian cancer
por: Hæe, Mette, et al.
Publicado: (2022)

Comparison of General Population, Patient, and Carer Utility Values for Dementia Health States
por: Rowen, Donna, et al.
Publicado: (2015)

Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
por: Tan, David SP, et al.
Publicado: (2021)

Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009)

Description approaches and automated generalization algorithms for groups of map objects
por: Yan, Haowen
Publicado: (2019)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Treatment for Recurrent Ovarian Cancer—At First Relapse
por: Ushijima, Kimio
Publicado: (2010)

The Role of Secondary Surgery in Recurrent Ovarian Cancer
por: Lorusso, D., et al.
Publicado: (2012)

Introduction to managing patients with recurrent ovarian cancer
por: Gabra, Hani
Publicado: (2014)

Cardiac Tamponade Unmasking Recurrent Ovarian Cancer
por: Maryniak, Andrii, et al.
Publicado: (2021)

Utility and limitations of coherent mapping algorithm utilizing vectors and global propagation patterns in atrial tachycardia
por: Yagishita, Atsuhiko, et al.
Publicado: (2023)

Remote Recurrence from Ovarian Cancer Mimicking Lung Cancer
por: Yamada, Sho, et al.
Publicado: (2021)

Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
por: Huang, Zhiqing, et al.
Publicado: (2023)

A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms
por: Michel, Yvonne Anne, et al.
Publicado: (2018)

Shapley-Based Estimation of Company Value—Concept, Algorithms and Parameters
por: Mercik, Jacek, et al.
Publicado: (2021)

Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
por: Hughes, Derralynn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mgrmqguco3n63guva8ugjcvnq4